Body mass index, immune status, and virological control in HIV-infected men who have sex with men

Journal of the International Association of Providers of AIDS Care

Volumn 12, Issue 5, 2013, Pages 319-324

  Blashill, Aaron J ^a,b,c   Mayer, Kenneth H ^a,c,d   Crane, Heidi M ^e   Grasso, Chris ^c   Safren, Steven A ^a,b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c FENWAY INSTITUTE   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

body mass index; CD4; HIV AIDS; obesity; viral load

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; BODY MASS; CD4 LYMPHOCYTE COUNT; CLINICAL ASSESSMENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; OBESITY; PRIORITY JOURNAL; VIRUS LOAD;

BODY MASS INDEX; CD4; HIV/AIDS; OBESITY; VIRAL LOAD;

ADULT; ANALYSIS OF VARIANCE; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY MASS INDEX; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OBESITY; UNITED STATES; VIRAL LOAD;

EID: 84884699100     PISSN: 23259574     EISSN: 23259582     Source Type: Journal    
DOI: 10.1177/2325957413488182     Document Type: Article

References (25)

1. Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab. 2004 ; 89 (6). 2583-2589
2. Marti A, Marcos A, Martinez JA. Obesity and immune function relationships. Obes Rev. 2001 ; 2 (2). 131-140
3. Falagas ME, Kompoti M. Obesity and infection. Lancet Infect Dis. 2006 ; 6 (7). 438-446
4. Keithley JK, Duloy AM, Swanson B, Zeller JM. HIV infection and obesity: a review of the evidence. J Assoc Nurses AIDS Care. 2009 ; 20 (4). 260-274
5. Jones CY, Hogan JW, Snyder B, et al. Overweight and human immunodeficiency virus (HIV) progression in women: associations HIV disease progression and changes in body mass index in women in the HIV epidemiology research study cohort. Clin Infect Dis. 2003 ; 37 (suppl 2). S69 - S80
6. Shor-Posner G, Campa A, Zhang G, et al. When obesity is desirable: a longitudinal study of the Miami HIV-1-infected drug abusers (MIDAS) cohort. J Acquir Immune Defic Syndr. 2000 ; 23 (1). 81-88
7. Shuter J, Chang CJ, Klein RS. Prevalence and predictive value of overweight in an urban HIV care clinic. J Acquir Immune Defic Syndr. 2001 ; 26 (3). 291-297
8. Quach LA, Wanke CA, Schmid CH, et al. Drug use and other risk factors related to lower body mass index among HIV-infected individuals. Drug Alcohol Depend. 2008 ; 95 (1-3). 30-36
9. Tedaldi EM, Brooks JT, Weidle PJ, et al. Increased body mass index does not alter response to initial highly active antiretroviral therapy in HIV-1-infected patients. J Acquir Immune Defic Syndr. 2006 ; 43 (1). 35-41
10. Crum-Cianflone N, Tejidor R, Medina S, Barahona I, Ganesan A. Obesity among patients with HIV: the latest epidemic. AIDS Patient Care STDS. 2008 ; 22 (12). 925-930
11. Crum-Cianflone NF, Roediger M, Eberly LE, et al. Impact of weight on immune cell counts among HIV-infected persons. Clin Vaccine Immunol. 2011 ; 18 (6). 940-946
12. Kitahata MM, Rodriguez B, Haubrich R, et al. Cohort profile: the centers for AIDS research network of integrated clinical systems. Int J Epidemiol. 2008 ; 37 (5). 948-955
13. Fredericksen R, Crane PK, Tufano J, et al. Integrating a web-based, patient-administered assessment into primary care for HIV-infected adults. J Acquir Immune Defic Dyndr. 2012 ; 4 (2). 47-55
14. Lawrence ST, Willig JH, Crane HM, et al. Routine, self-administered, touch-screen, computer-based suicidal ideation assessment linked to automated response team notification in an HIV primary care setting. Clin Infect Dis. 2010 ; 50 (8). 1165-1173
15. Crane HM, Lober W, Webster E, et al. Routine collection of patient-reported outcomes in an HIV clinic setting: the first 100 patients. Curr HIV Res. 2007 ; 5 (1). 109-118
16. Spitzer R, Kroenke K, Williams J.. Validation and utility of a self-report version of PRIME-MD: The PHQ Primary Care Study. JAMA. 1999 ; 282 (18). 1737-1744
17. Janssen I, Katzmarzyk PT, Ross R. Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines. Arch Intern Med. 2002 ; 162 (18). 2074-2049
18. West BT. Analyzing longitudinal data with the linear mixed models procedure in SPSS. Eval Health Prof. 2009 ; 32 (3). 207-228
19. Koethe JR, Jenkins CA, Shepherd BE, Stinnette SE, Sterling TR. An optimal body mass index range associated with improved immune reconstitution among HIV-infected adults initiating antiretroviral therapy. Clin Infect Dis. 2011 ; 53 (9). 952-960
20. Sørensen TI, Echwald S, Holm JC. Leptin in obesity. BMJ. 1996 ; 313 (7063). 953-954
21. Mantzoros CS. The role of leptin in human obesity and disease: a review of current evidence. Ann Intern Med. 1999 ; 130 (8). 671-680
22. Farooqi IS, Matarese G, Lord GM, et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest. 2002 ; 110 (8). 1093-1103
23. Kim SY, Lim JH, Choi SW, et al. Preferential effects of leptin on CD4 T cells in central and peripheral immune system are critically linked to the expression of leptin receptor. Biochem Biophys Res Commun. 2010 ; 394 (3). 562-568
24. Mulligan K, Khatami H, Schwarz JM, et al. The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypolepinemia. J Clin Endocrinol Metab. 2009 ; 94 (4). 1137-1144
25. Lee JH, Chan JL, Sourlas E, Raptopoulos V, Mantzoros CS. Recombinant methionyl human leptin therapy in replacement doses improved insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy. J Clin Endocrinol Metab. 2006 ; 91 (7). 2605-2611